evans blue has been researched along with Cognitive Decline in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, Q; Ji, H; Ju, Y; Liu, B; Wang, J; Wen, Q; Xu, S; Yin, Y | 1 |
1 other study(ies) available for evans blue and Cognitive Decline
| Article | Year |
|---|---|
Cortistatin-14 Exerts Neuroprotective Effect Against Microglial Activation, Blood-brain Barrier Disruption, and Cognitive Impairment in Sepsis-associated Encephalopathy.
Topics: Animals; Blood-Brain Barrier; Cognitive Dysfunction; Cytokines; Disease Models, Animal; Evans Blue; Interferon-gamma; Interleukin-1beta; Interleukin-6; Mice; Microglia; Neuropeptides; Neuroprotective Agents; Peptides, Cyclic; Sepsis; Sepsis-Associated Encephalopathy; Tumor Necrosis Factor-alpha | 2022 |